Literature DB >> 15950640

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.

Mohammed Salleh M Ardawi1, Abdulrahim A Rouzi.   

Abstract

OBJECTIVE: To determine plasma adiponectin concentration in women with and without polycystic ovary syndrome (PCOS) and to assess possible correlations of adiponectin to the hormonal and metabolic parameters, including measures of insulin resistance (IR).
DESIGN: Case-control study.
SETTING: Tertiary-referral university hospital. PATIENT(S): One hundred eighty selected women were classified as follows: 45 obese (body mass index [BMI] >30 kg/m2) with PCOS; 45 lean (BMI <25 kg/m2) with PCOS; 45 obese (BMI >30 kg/m2) without PCOS, and 45 lean (BMI <25 kg/m2) without PCOS. INTERVENTION(S): Blood samples were collected from all women with or without PCOS between 8 and 11 am, after an overnight fast. MAIN OUTCOME MEASURE(S): Serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), free T4, testosterone (T), 17-alpha-hydroxyprogesterone, Delta4-androstenedione (Delta4-A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), sex hormone-binding globulin (SHBG), insulin, and plasma levels of adiponectin and glucose. Measures of IR included fasting serum insulin, glucose-to-insulin ratio, and homeostasis model assessment (HOMA). RESULT(S): Adiponectin concentrations were found to be significantly decreased in women with PCOS and in obese women without PCOS as compared with lean women without PCOS. Adiponectin concentrations correlated inversely with body weight, BMI, fasting plasma glucose, serum insulin, Delta4-A, DHEA, DHEAS, and HOMA but correlated positively with serum T, SHBG, FAI, and glucose-to-insulin ratio. Multiple regression analysis showed that BMI, HOMA, Delta4-A, and insulin were independent determinants of adiponectin concentrations. CONCLUSION(S): Hypoadiponectinemia is evident in obese and lean women with PCOS with variable degree of IR; and it is suggested that IR per se or other metabolic abnormalities of PCOS are involved in the regulation of adiponectin concentration in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950640     DOI: 10.1016/j.fertnstert.2004.11.077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome.

Authors:  Edmond P Wickham; Kai I Cheang; John N Clore; Jean-Patrice Baillargeon; John E Nestler
Journal:  Metabolism       Date:  2010-03-31       Impact factor: 8.694

2.  Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.

Authors:  Hugo H Ortega; Florencia Rey; Melisa M L Velazquez; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

3.  Sex hormones and adipokines in healthy pre-menopausal, post-menopausal and elderly women, and in age-matched men: data from the Brisighella Heart study.

Authors:  A F G Cicero; P Magni; P Lentini; M Ruscica; E Dozio; F Strollo; C Borghi
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

4.  Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human.

Authors:  JoAnne S Richards; Zhilin Liu; Tomoko Kawai; Kei Tabata; Hirohiko Watanabe; Deepa Suresh; Fang-Ting Kuo; Margareta D Pisarska; Masayuki Shimada
Journal:  Fertil Steril       Date:  2012-05-26       Impact factor: 7.329

Review 5.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

6.  Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3τ interaction domain with a canonical G-protein interaction site.

Authors:  James A Dias; Smita D Mahale; Cheryl A Nechamen; Olga Davydenko; Richard M Thomas; Alfredo Ulloa-Aguirre
Journal:  Mol Cell Endocrinol       Date:  2010-06-19       Impact factor: 4.102

Review 7.  Adiponectin and polycystic ovary syndrome.

Authors:  Susan W Groth
Journal:  Biol Res Nurs       Date:  2010-05-24       Impact factor: 2.522

8.  Prediction of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Fırat Ersan; Esra Arslan; Aytül Çorbacıoğlu Esmer; Serdar Aydın; Asuman Gedikbaşı; Ali Gedikbaşı; Ismet Alkış; Cemal Ark
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

9.  Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS.

Authors:  Tayebe Artimani; Massoud Saidijam; Reza Aflatoonian; Mahnaz Ashrafi; Iraj Amiri; Mahnaz Yavangi; Sara SoleimaniAsl; Nooshin Shabab; Jamshid Karimi; Mehdi Mehdizadeh
Journal:  J Assist Reprod Genet       Date:  2015-12-02       Impact factor: 3.412

10.  ADIPONECTIN AS A SERUM MARKER OF ADIPOSE TISSUE DYSFUNCTION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: CORRELATION WITH INDICATORS OF METABOLIC DISTURBANCES.

Authors:  A Atanasova Boshku; D Ivanova Panova; B Zafirova Ivanovska
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.